We are committed to unlocking fundamentally different therapeutic approaches and creating new solutions through bold science and our unique drug discovery platform.
Named for the visual resemblance of a scholar rock to protein structures, Scholar Rock is advancing innovative treatments where protein growth factors are fundamental. Over the past decade, we have created a pipeline with the potential to advance the standard of care for neuromuscular disease and other conditions where growth factor-targeted drugs can play a transformational role.Learn About Our Science
Scholar Rock works across therapeutic areas and shines new light on the overlooked to better target disease.
We are on a mission to discover, develop, and deliver life-changing therapies. We promote a spirit of curiosity and collaboration with the goal of achieving the best results for patients.
November 17, 2023
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 7, 2023
Scholar Rock Reports Third Quarter 2023 Financial Results and Highlights Business Progress
November 3, 2023
Scholar Rock Presents New Data from Phase 1 DRAGON Trial Showing Promising Anti-Tumor Activity in Anti-PD-1 Resistant Metastatic ccRCC Patients and Supporting SRK-181 Continued Tolerability